Group 1 - The core announcement is that Gansu Shafeng Cement Co., Ltd. has invested in Yuexin Semiconductor Technology Co., Ltd., which has received approval for its initial public offering (IPO) on the ChiNext board [1] - Shafeng Cement has maintained a top-three position in the industry for gross margin and ROE (Return on Equity) for several years, and has initiated a "self-revolution" since 2020, investing approximately 2 billion yuan in the semiconductor industry chain [1] - The company has established a complete investment matrix covering equipment, design, manufacturing, and materials through investments in leading manufacturers and material companies [1] Group 2 - The IPO of Yuexin Semiconductor is expected to alleviate the funding bottleneck for capacity expansion and accelerate the technological industrialization process [2] - Shafeng Cement's investment has already proven valuable, with the previous project with Jinghe Integrated Circuit Co., Ltd. generating a net profit of 166 million yuan [2] - The strategic collaboration aims to bind core resources of the semiconductor industry chain, laying the groundwork for future extensions into new material production [2] Group 3 - The company plans to continue increasing investments in the semiconductor and new energy sectors, adopting a model that integrates industrial investment, technology incubation, and resource integration to build a new materials industry cluster [3]

Group 1 - Guanshang Technology is planning to issue shares to acquire assets and will suspend trading from December 22, 2025, with a transaction plan expected to be disclosed within 10 trading days [1] - *ST Dongyi's restructuring plan has been approved by the Beijing First Intermediate People's Court, entering the execution phase, which may improve the company's financial structure and impact its 2025 financial data [1] - Victory Energy's stock has hit the limit up for six consecutive trading days, with a total increase of 77.22%, indicating a significant deviation from market trends and a high risk of rapid decline [1] Group 2 - Shangfeng Cement's investee company, Yuexin Semiconductor, has received approval for its IPO application on the ChiNext board [2] - Jindalai plans to invest 30 million yuan in Zhongke Hongtai Medical Technology, acquiring a 10% stake in the company, which specializes in medical robotics [2] - Lianchuang Electronics is planning a change of control, leading to continued suspension of its stock from December 22, 2025 [3] Group 3 - Health元's subsidiary has received approval for clinical trials of NS-041 tablets for treating depression, marking a significant development in the KCNQ2/3 targeted drug market [3] - Xihua Technology will be listed on the Shanghai Stock Exchange on December 23, 2025, with an initial public offering of 100 million shares [4] - *ST Mingjia has completed a capital reserve transfer to increase its share capital by 730 million shares, with its stock resuming trading on December 22, 2025 [4] Group 4 - Kerryde's major shareholder plans to reduce its stake by up to 3%, amounting to a maximum of 11.03 million shares [4] - Delinhai's vice chairman intends to reduce his holdings by up to 196,000 shares, representing no more than 0.17% of the total share capital [5] - Zhongchuang Zhiling's chairman and vice presidents plan to reduce their shares by specified amounts [6] Group 5 - Mercury Home Textiles' actual controller and board members plan to reduce their holdings by up to 1.72% of the total shares, with specific amounts outlined for each individual [7]

Group 1 - *ST Dongyi's restructuring plan has been approved by the court, marking the end of its restructuring process and entering the execution phase, which is expected to improve the company's financial structure and promote sustainable development [1] - Guankang Technology is planning to acquire at least 60% of Liaojing Electronics' shares, leading to a suspension of trading starting December 22, 2025, due to uncertainties surrounding the transaction [2] - Zhuoran Co. and its actual controller are under investigation for suspected violations of information disclosure laws, but the company's operations remain normal during this period [3] Group 2 - China Shenhua plans to issue A-shares and pay cash to acquire assets from its controlling shareholder, with a total transaction value of 133.598 billion yuan, which will significantly enhance its coal resource reserves and production capacity [5] - Bohai Chemical has decided to terminate its major asset restructuring plan due to a lack of agreement on key terms, with trading resuming on December 22, 2025 [6] - Jinshi Resources intends to acquire a 15.7147% stake in Noah Fluorine Chemical for approximately 256.94 million yuan, which will strengthen its position in the fluorine chemical sector [8] Group 3 - Qingdao Port plans to invest 9.097 billion yuan in the construction of a container terminal, with an expected internal rate of return of 8.15% [13] - Tianchuang Fashion is undergoing a potential change in control, leading to a suspension of its stock starting December 22, 2025, for a maximum of two trading days [12] - Deyu Water Conservancy has won a bid for a significant irrigation project in Guangxi, with a contract value of 1 billion yuan, which is expected to positively impact future earnings [15] Group 4 - The stock of Guizhou Bailin will be suspended for one day starting December 22, 2025, due to an administrative penalty notice, and will resume trading under the name "ST Bailin" [20] - *ST Weihai's stock will also be suspended for one day and will resume trading on December 23, 2025, with the removal of certain risk warnings [23] - Tianpu Co. has completed a public offering of shares, with a total of 33.52 million shares being offered at a price of 23.98 yuan per share [21]

Major Announcements - Jinshi Resources plans to acquire 15.71% equity in Noah Fluorine Chemical for 256.94 million yuan, becoming the second-largest shareholder, which aligns with its strategy to extend into high-value fine fluorine chemical sectors [4] - Victory Energy's stock has seen a significant increase of 77.22% over six consecutive trading days, leading to high volatility and potential rapid decline risks due to deviation from its fundamental business [2] - Sanxiang Impression confirms normal operations and states there are no undisclosed significant matters despite recent stock price fluctuations [3] Corporate Developments - Zaiying Pharmaceutical has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange, pending approvals from regulatory bodies [5] - Nanhua Futures' overseas subsidiary has been approved as a trading and clearing member of IFSG and ICSG, enhancing its trading capabilities [6] - Xihua Technology is set to list on the Shanghai Stock Exchange on December 23, 2025, with an initial public offering of 100 million shares [7] Financial Transactions - Jindalai plans to invest 30 million yuan in Zhongke Hongtai, acquiring a 10% stake, focusing on the medical robotics sector [8] - Xiamen Tungsten has redeemed 280 million yuan in principal and earned 2.75 million yuan from structured deposit products [9] - *ST Dongyi's restructuring plan has been approved by the court, allowing the company to enter the execution phase of its restructuring [10] Market Reactions - Wan Tong Development's major shareholder has had 364 million shares frozen due to loan disputes, affecting 19.28% of the total share capital [10] - Zhenghai Magnetic Materials won an international arbitration case, which will positively impact its current operating performance [11] - Shandong Heda received a favorable ruling in the U.S. on anti-dumping and countervailing duties, which will reduce tax liabilities and positively affect its financial performance [11] Regulatory Updates - Aihong Pharmaceutical's product APLD-2304 has received acceptance for medical device registration in the EU, targeting bladder cancer diagnostics [12] - Keli'er has terminated a strategic cooperation agreement due to changes in market conditions, with no significant impact on its operations [12] - Health元's subsidiary has received approval for clinical trials of a new drug targeting depression, marking a significant development in the KCNQ2/3 drug market [13]

Investment Rating - The report highlights a positive outlook for the construction and building materials sector, particularly focusing on high dividend stocks like Sichuan Road and Bridge, which has a projected dividend yield of approximately 5.6% by the end of 2025 [2] Core Insights - The report emphasizes the increasing interest from insurance capital in high dividend stocks within the construction and building materials sector, as evidenced by the significant share purchases in companies like Sichuan Road and Bridge [2] - It suggests that the AI new materials industry is experiencing rapid changes, with a recommendation to adopt a "steady response" strategy due to the high frequency of market fluctuations [3] - The report advocates for overseas expansion, particularly in African markets, as lower interest rates are easing external debt pressures and creating opportunities for investment [4] Summary by Sections Weekly Discussion - China Post Insurance has acquired a 5% stake in Sichuan Road and Bridge, investing a total of 3.9 billion [2] - Other companies targeted by China Post Insurance include Eastern Airlines Logistics and Green Power Environmental Protection, indicating a broader trend of insurance capital entering the high dividend segment of the construction sector [2] Industry Trends - The AI new materials sector is seeing increased participation from domestic and international manufacturers, with a focus on stability amidst rapid changes [3] - Companies like Zhongcai Technology and Copper Crown Copper Foil are highlighted as leaders in the AI materials space, with strong technology and cost advantages [3] Market Performance - The report notes a decline in cement prices, with the national average price at 354 RMB per ton, down 67 RMB year-on-year [5] - Glass prices have also decreased, with the average price for float glass at 1151.40 RMB per ton, reflecting a 1.17% drop [5] Important Developments - Significant investments and project wins were reported, including a 4.32 billion RMB project win by Shenghui Integration in Thailand [6] - Sichuan Road and Bridge's share acquisition by China Post Insurance is expected to attract more attention to high dividend stocks in the construction sector [6]

经合并统计计算，公司间接持有此次公开发行上市前粤芯半导体的股权比例约为1.4957%。 人民财讯12月21日电，上峰水泥（000672）12月21日公告，公司通过全资子公司宁波上融物流有限公司 为出资主体分别与专业机构合资成立的私募股权投资基金——上海芯濮然创业投资合伙企业(有限合 伙)、苏州晶璞创业投资合伙企业(有限合伙)及苏州工业园区储芯创业投资合伙企业(有限合伙)投资的粤 芯半导体技术股份有限公司(简称"粤芯半导体")首次公开发行股票(IPO)并在创业板上市申请于12月19日 获深交所受理。 ...

智通财经APP讯，上峰水泥(000672.SZ)发布公告，近日获悉，公司通过全资子公司宁波上融物流有限公 司为出资主体分别与专业机构合资成立的私募股权投资基金—上海芯濮然创业投资合伙企业(有限合 伙)、苏州晶璞创业投资合伙企业(有限合伙)及苏州工业园区储芯创业投资合伙企业(有限合伙)投资的粤 芯半导体技术股份有限公司(简称"粤芯半导体")首次公开发行股票并在创业板上市申请于2025年12月19 日获深圳证券交易所受理。经合并统计计算，公司间接持有本次公开发行上市前粤芯半导体的股权比例 约为1.4957%。 ...

智通财经APP讯，上峰水泥(000672.SZ)发布公告，近日获悉，公司通过全资子公司宁波上融物流有限公 司为出资主体分别与专业机构合资成立的私募股权投资基金—上海芯濮然创业投资合伙企业(有限合 伙)、苏州晶璞创业投资合伙企业(有限合伙)及苏州工业园区储芯创业投资合伙企业(有限合伙)投资的粤 芯半导体技术股份有限公司(简称"粤芯半导体")首次公开发行股票并在创业板上市申请于2025年12月19 日获深圳证券交易所受理。经合并统计计算，公司间接持有本次公开发行上市前粤芯半导体的股权比例 约为1.4957%。 ...

证券代码：000672 证券简称：上峰水泥 公告编号：2025-082 甘肃上峰水泥股份有限公司 特此公告。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 甘肃上峰水泥股份有限公司（以下简称"公司"）近日获悉，公司通过全资 子公司宁波上融物流有限公司（以下简称"宁波上融"）为出资主体分别与专业机 构合资成立的私募股权投资基金——上海芯濮然创业投资合伙企业（有限合伙） （以下简称"上海芯濮然"）、苏州晶璞创业投资合伙企业（有限合伙）（以下简 称"苏州晶璞"）及苏州工业园区储芯创业投资合伙企业（有限合伙）（以下简称 "苏州储芯"）投资的粤芯半导体技术股份有限公司（以下简称"粤芯半导体"） 首次公开发行股票并在创业板上市申请于 2025 年 12 月 19 日获深圳证券交易所 受理。 《招股说明书（申报稿）》显示：粤芯半导体是一家致力于为境内外芯片设 计企业提供 12 英寸晶圆代工服务和特色工艺解决方案的集成电路制造企业。以 特色工艺晶圆代工为核心商业模式，服务芯片设计公司和终端客户，主要客户涵 盖境内外多家一流半导体行业设计公司。粤芯半导体具备集成电路、功率器件 ...

上峰水泥公告称，其通过全资子公司宁波上融参投的私募股权投资基金，所投粤芯半导体于2025年12月 19日创业板上市申请获深交所受理。截至2025年6月30日，粤芯半导体获授权专利681项。截至公告日， 宁波上融出资2.34亿元，通过三只基金间接持粤芯半导体1.4957%股权。此次上市尚需深交所审核及证 监会同意注册，存在不确定性。 ...